tetano
Editor, Senior Moderator
Pediatr Infect Dis J
. 2024 Feb 19.
doi: 10.1097/INF.0000000000004301. Online ahead of print. SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19
Dimitra Dimopoulou[SUP] 1 [/SUP], Marietta Charakida[SUP] 1 [/SUP], Antonios Marmarinos[SUP] 2 [/SUP], Dareilena Karaviti[SUP] 1 [/SUP], Margaritis Avgeris[SUP] 2 [/SUP], Dimitrios Gourgiotis[SUP] 2 [/SUP], Maria N Tsolia[SUP] 1 [/SUP]
Affiliations
Background: Antibody levels decline a few months post-acute COVID-19, but humoral memory persists in adults. Age and disease severity may affect antibody responses. This study aims to evaluate the presence and durability of antibody responses in children with COVID-19.
Methods: A prospective, single-center study, involving unvaccinated children 0-16 years old who were hospitalized with COVID-19 between October 2020 and December 2021, was conducted. Serological testing for anti-Spike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG and neutralizing antibodies was performed at diagnosis and at 1-, 3-, 6- and 12-months post-infection.
Results: A total of 65 immunocompetent children were enrolled [mean age (±SD): 6.7 (±6.4) years; males: 56.9%]. At 3 months, 40/44 (91%) children were seropositive; seropositivity persisted in 22/26 (85%) children at 6 months and in 10/12 (83%) children at 12 months. There was no evidence that age was modifying the prediction of variance of SARS-CoV-2 IgG levels. In contrast, SARS-CoV-2 IgG levels varied with time and disease severity. The association with time was non-linear, so that with increasing time there was a significant reduction in SARS-CoV-2 IgG levels [coef, 0.044 (95% confidence interval {CI}: 0.061-0.028), P < 0.001]. For each increment of time, the higher disease severity group was associated with 0.9 lower SARS-CoV-2 IgG levels. Everyone varied from the average effect of time with an SD of 0.01, suggesting that individuals may have different trajectories across time.
Conclusion: Disease severity, but not age, influences antibody titers among children hospitalized with COVID-19. SARS-CoV-2 infection induces durable seroconversion in these children with detectable IgG levels at 1 year after infection.
. 2024 Feb 19.
doi: 10.1097/INF.0000000000004301. Online ahead of print. SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19
Dimitra Dimopoulou[SUP] 1 [/SUP], Marietta Charakida[SUP] 1 [/SUP], Antonios Marmarinos[SUP] 2 [/SUP], Dareilena Karaviti[SUP] 1 [/SUP], Margaritis Avgeris[SUP] 2 [/SUP], Dimitrios Gourgiotis[SUP] 2 [/SUP], Maria N Tsolia[SUP] 1 [/SUP]
Affiliations
- PMID: 38372544
- DOI: 10.1097/INF.0000000000004301
Background: Antibody levels decline a few months post-acute COVID-19, but humoral memory persists in adults. Age and disease severity may affect antibody responses. This study aims to evaluate the presence and durability of antibody responses in children with COVID-19.
Methods: A prospective, single-center study, involving unvaccinated children 0-16 years old who were hospitalized with COVID-19 between October 2020 and December 2021, was conducted. Serological testing for anti-Spike severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG and neutralizing antibodies was performed at diagnosis and at 1-, 3-, 6- and 12-months post-infection.
Results: A total of 65 immunocompetent children were enrolled [mean age (±SD): 6.7 (±6.4) years; males: 56.9%]. At 3 months, 40/44 (91%) children were seropositive; seropositivity persisted in 22/26 (85%) children at 6 months and in 10/12 (83%) children at 12 months. There was no evidence that age was modifying the prediction of variance of SARS-CoV-2 IgG levels. In contrast, SARS-CoV-2 IgG levels varied with time and disease severity. The association with time was non-linear, so that with increasing time there was a significant reduction in SARS-CoV-2 IgG levels [coef, 0.044 (95% confidence interval {CI}: 0.061-0.028), P < 0.001]. For each increment of time, the higher disease severity group was associated with 0.9 lower SARS-CoV-2 IgG levels. Everyone varied from the average effect of time with an SD of 0.01, suggesting that individuals may have different trajectories across time.
Conclusion: Disease severity, but not age, influences antibody titers among children hospitalized with COVID-19. SARS-CoV-2 infection induces durable seroconversion in these children with detectable IgG levels at 1 year after infection.